Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin vs Glimepiride for Microalbuminuria in T2DM
NCT02462369Phase 4Unknown
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Jun 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of saxagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoint: Microalbuminuria improvement at 52 weeks. Status: unknown.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02462369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462369.